SK Hynix is said to plan $12B special dividend from Kioxia investment (SKHY:NASDAQ)
SK Hynix (SKHY) plans a $12B special dividend, funded by gains from its investment in Kioxia Holdings, according to South Korea's DongA Ilbo.
1 min readBreaking, market-moving stock news with AI analysis, updated every minute. Ticker-linked, relevance-scored, ready for your agent.
SK Hynix (SKHY) plans a $12B special dividend, funded by gains from its investment in Kioxia Holdings, according to South Korea's DongA Ilbo.
1 min readThe Kospi index opened lower on Monday, down 0.92%, as investors await earnings reports from SK hynix and Samsung Electronics, and the U.S. Federal Reserve's decision. The index lost 2.08% last week due to foreign selling and semiconductor volatility. Oil prices slightly declined from a six-month high.
1 min readAstraZeneca presented positive late-stage trial data for its first fully owned antibody-drug conjugate (ADC), sone-ve, showing a 42% reduction in death risk for advanced gastric cancer patients. The company plans to file for regulatory approval, aiming to strengthen its position in the fast-growing oncology market. AstraZeneca estimates peak revenue of $3B-$5B for sone-ve and over $5B for its broader ADC portfolio.
2 min readSolana's stablecoin holders grew from 4M to 14M in October 2024, with total supply exceeding $15B. However, SOL's price fell 13% in 30 days, and DEX volume dropped 9%. Stablecoin flows remain mixed, with netflows near neutral. DeFi TVL is $5.77B, and daily fees are around $477k. Investors await increased activity to support SOL's price recovery.
2 min readOpenWorld (OPNW) plans to dual-list on Figure OPEN in Q4 2026, adding a blockchain-native share class without issuing new shares. The move aims for 24/7 settlement and no capital dilution, according to the company.
1 min readHUTCHMED and AstraZeneca announced positive Phase III trial results for ORPATHYS® (savolitinib) plus TAGRISSO® (osimertinib) in EGFR-mutated NSCLC with MET overexpression. The combo extended median overall survival by 4.9 months and reduced disease progression risk. Results were presented at ESMO and published in NEJM. NDAs have been submitted in the US, with submissions in Europe and Japan planned. ORPATHYS® is jointly developed by both companies and commercialized by AstraZeneca.
3 min readFF EAI Robotics Ecosystem Inc. (FFR) will hold its Listing Ceremony and Investor Day on October 26, 2026. Management will discuss future strategic direction and business plans. The event video will be available at 5:00 p.m. ET on the company's website. FF Founder YT Jia's Investor Weekly Report has been rescheduled to the same date.
1 min readSolana led inflows in tokenised funds with $453.5M, 73% of total, while Ethereum saw a $26M market cap drop. Tether expanded its user base by 1.7M wallets. Franklin Templeton and JPMorgan added $33.9M and $33.6M respectively. The report highlights shifts in liquidity and user growth among blockchains and issuers.
2 min readAnalyst Ali Martinez, cited by U.Today, warns XRP could fall to $0.98 if whale selling continues. Data shows large wallets decreased and exchange inflows rose, increasing supply pressure. XRP is trading around $1.30, with $1.26 as a key support level.
2 min readSamsung Electronics launched the 'Galaxy Buds On,' clip-style wireless earbuds priced at 299,000 won, available from the 27th. Features include a comfortable fit, rich sound, and clear call quality. Purchases come with discounts on accessories. The product is compatible with 'Galaxy Buds4 series' accessories and offers hands-free functions when connected to Galaxy AI devices.
1 min read